z-logo
open-access-imgOpen Access
Paritaprevir+Ritonavir+Ombitasvir+Dasabuvir±Ribavirin treatment in HCV infected chronic hemodialysis patients: A single center experience
Author(s) -
Nilay Danış,
Hüsnü Pullukçu,
Tansu Yamazhan,
Galip Ersöz,
Nalan Gülşen Ünal,
Fulya Günşar,
İlker Turan,
Zeki Karasu,
Ulus Salih Akarca
Publication year - 2019
Publication title -
the turkish journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.404
H-Index - 28
eISSN - 2148-5607
pISSN - 1300-4948
DOI - 10.5152/tjg.2019.09
Subject(s) - medicine , ombitasvir , dasabuvir , ribavirin , ritonavir , paritaprevir , hemodialysis , virology , chronic hepatitis , viral load , human immunodeficiency virus (hiv) , virus , antiretroviral therapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom